Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diseases of the Thyroid
  Free Subscription

Articles published in
Eur Thyroid J
    October 2025
  1. JAGER EC, Sondorp LHJ, Maturi R, Antunes IF, et al
    Patient-derived medullary thyroid cancer organoids: a potential model for mechanistic studies on diagnostics and therapy.
    Eur Thyroid J. 2025;14:e240405.
    >> Share

  2. VIRGINIA C, Antonio M, Valeria B, Alessandro P, et al
    Multifocality and bilaterality in medullary thyroid cancer: basis for a proof-of-concept safety of lobectomy.
    Eur Thyroid J. 2025;14:e250074.
    >> Share

  3. QUATTROCHI F, Grunenwald S, Caron P
    Apalutamide treatment and refractory hypothyroidism: effects of apalutamide on levothyroxine metabolism.
    Eur Thyroid J. 2025;14:e250185.
    >> Share

  4. TOFT KRISTENSEN T, Plaschke CC, Fog Lomholt A, Holst Hahn C, et al
    Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer.
    Eur Thyroid J. 2025;14:e240282.
    >> Share

  5. LEE ACH, Kahaly GJ
    Unravelling the pathogenic mechanisms in Graves' orbitopathy.
    Eur Thyroid J. 2025;14:e250200.
    >> Share

    August 2025
  6. WANG J, Teng D, Yang K, Liu S, et al
    Long-term exposure to PM1 and thyroid diseases in China.
    Eur Thyroid J. 2025;14:e250106.
    >> Share

  7. CERUTI D, Ottevanger PB, De Leo S, Bonenkamp HJ, et al
    Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies.
    Eur Thyroid J. 2025;14:e250161.
    >> Share

  8. RIOS-MORRIS E, Tientcheu Ngaffi VI, Costagliola S, Romitti M, et al
    NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Development of 3D organoid models to study aggressive thyroid cancers.
    Eur Thyroid J. 2025;14:e240392.
    >> Share

  9. TAPROGGE J, Murray I, Sharman H, Gape P, et al
    Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.
    Eur Thyroid J. 2025;14:e250097.
    >> Share

  10. ZABLOTSKA LB, McConnell RJ, Rozhko AV, O'Kane P, et al
    Validation of established thyroid ultrasound volume norms in a Chernobyl cohort.
    Eur Thyroid J. 2025;14:e250085.
    >> Share

  11. XU S, Peng Y, Li X, Li H, et al
    TSHR in thyroid cancer: bridging biological insights to targeted strategies.
    Eur Thyroid J. 2025;14:e240369.
    >> Share

  12. TRIMBOLI P, Makovac P, Colombo A, Ruinelli L, et al
    Analysis of FNAC indication in thyroid nodules assessed as low risk according to various TIRADSs.
    Eur Thyroid J. 2025;14:e250113.
    >> Share

  13. LUNDGAARD MH, Bruun NH, Andersen S, Andersen SL, et al
    Birth weight and placental weight in children born to mothers with hypothyroidism.
    Eur Thyroid J. 2025;14:e250111.
    >> Share

  14. RYSKA A, Capdevila J, Dettmer MS, Elisei R, et al
    Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus.
    Eur Thyroid J. 2025;14:e250024.
    >> Share

  15. KASAHARA T
    The relationship between levothyroxine dosage and free thyroxine levels in hypothyroid patients: a large retrospective study.
    Eur Thyroid J. 2025;14:e240388.
    >> Share

  16. MEGIER C, Luton D, Stoupa A
    50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Management during pregnancy and long-term outcomes of adult patients with congenital hypothyroidism.
    Eur Thyroid J. 2025;14:e250125.
    >> Share

  17. STAN MN, Dosiou C
    The evolving therapeutic landscape of Graves' disease in adults: present and future.
    Eur Thyroid J. 2025;14:e250078.
    >> Share

  18. CENTANNI M, Duntas L, Feldt-Rasmussen U, Koehrle J, et al
    ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism.
    Eur Thyroid J. 2025;14:e250123.
    >> Share

  19. KUHLEN M, Kunstreich M, Eilsberger F, Lorenz K, et al
    Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group.
    Eur Thyroid J. 2025;14:e250035.
    >> Share

  20. VINCENZI G, Petralia IT, Abbate M, Vigone MC, et al
    50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Transient or permanent congenital hypothyroidism: from milestones to current and future perspectives.
    Eur Thyroid J. 2025;14:e250019.
    >> Share

    June 2025
  21. KYRIACOU A, Vryza P, Kyriacou A, Picolos M, et al
    Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism.
    Eur Thyroid J. 2025;14:e240373.
    >> Share

  22. GRIXTI L, Fisher H, Priestley J, McMullan C, et al
    Prevalence and severity of fatigue in treated hypothyroidism: results of a UK survey.
    Eur Thyroid J. 2025;14:e250044.
    >> Share

  23. SESTI F, Feola T, Dolce P, Guarnotta V, et al
    Role of the calcium stimulation test in diagnosing medullary thyroid cancer: is it adequate to achieve a diagnosis in both sexes? An individual patient data meta-analysis.
    Eur Thyroid J. 2025;14:e240347.
    >> Share

  24. KARIMI AH, Zeng PY, Cecchini M, Barrett JW, et al
    NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.
    Eur Thyroid J. 2025;14:e250057.
    >> Share

  25. PASCHKE R, Ghaznavi S, Imran SA, Jacquier J, et al
    Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada.
    Eur Thyroid J. 2025;14:e250072.
    >> Share

  26. PIEKIELKO-WITKOWSKA A, Duda MK, Boguslawska J, Mackiewicz U, et al
    The impact of autoimmune thyroid disease on cognitive and psychiatric disorders: focus on clinical, pre-clinical and molecular studies.
    Eur Thyroid J. 2025;14:e240406.
    >> Share

  27. MANSO J, Muller I, Mian C
    Clinical management of alemtuzumab-induced autoimmune thyroid diseases: a narrative review.
    Eur Thyroid J. 2025;14:e250007.
    >> Share

  28. CONDELLO V, Doerfler WR, Nikitski AV, Spagnolo DM, et al
    Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility.
    Eur Thyroid J. 2025;14:e250022.
    >> Share

  29. LIU X, Cui L, Dong J, Ren J, et al
    Potential of bone marrow mesenchymal stem cells in iodine-induced autoimmune thyroiditis therapy.
    Eur Thyroid J. 2025;14:e240137.
    >> Share

  30. NESET MT, Ulvik A, Lovas K, Laupsa-Borge J, et al
    Insight into the metabolic shifts in Graves' hyperthyroidism: a study of acylcarnitine and lipid profiles.
    Eur Thyroid J. 2025;14:e250004.
    >> Share

  31. MORITANI S, Takenobu M, Yasunaga M, Fujii T, et al
    Usefulness of local therapy for distant metastases of differentiated thyroid cancer.
    Eur Thyroid J. 2025;14:e240237.
    >> Share

  32. COSTE J, Mandereau-Bruno L, Bertagna X, Wemeau JL, et al
    Prevalence of treated hyper- and hypo-thyroidism and sociodemographic and geographic disparities in France in 2020.
    Eur Thyroid J. 2025;14:e250041.
    >> Share

    April 2025
  33. GROB F, Lain S, Olivieri A
    Newborn screening for primary congenital hypothyroidism: past, present and future.
    Eur Thyroid J. 2025;14:e240358.
    >> Share

  34. NYGAARD B, Jensen CZ, Jorsal M, Medici BR, et al
    Long-term outcomes of LT4/LT3 combination treatment for persistent hypothyroid symptoms.
    Eur Thyroid J. 2025;14:e240275.
    >> Share

  35. URKEN ML, Brandwein-Weber M, Chai RL, Zafereo M, et al
    An anatomic checklist for accurate staging of grossly invasive thyroid cancer.
    Eur Thyroid J. 2025;14:e240289.
    >> Share

  36. LI T, Gui Y, Cui X, Wu X, et al
    Comparison of short-term outcomes following minimally invasive (endoscopic/robotic) vs open thyroidectomy for patients with thyroid cancer.
    Eur Thyroid J. 2025;14:e240134.
    >> Share

  37. YAMAZAKI H, Sugino K, Inoue K, Katoh R, et al
    Analysis of immediate 503 thyroid carcinoma deaths: trend of single institution in 2005-2024.
    Eur Thyroid J. 2025;14:e240368.
    >> Share

  38. EFFRAIMIDIS G, Sazakli E, Karapanou O, Saltiki K, et al
    Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for change.
    Eur Thyroid J. 2025;14:e250013.
    >> Share

  39. HIROMASA T, Wakabayashi H, Watanabe S, Yamase T, et al
    Enhancing radioactive iodine (RAI) incorporation in RAI-refractory differentiated thyroid cancer: current insights.
    Eur Thyroid J. 2025;14:e240319.
    >> Share

  40. DIEZ JJ, Galofre JC
    Management of benign nodular thyroid disease: a nationwide survey of endocrine specialists in Spain.
    Eur Thyroid J. 2025;14:e240313.
    >> Share

  41. STOUPA A, Carre A, Polak M, Szinnai G, et al
    Genetics of primary congenital hypothyroidism: three decades of discoveries and persisting etiological challenges.
    Eur Thyroid J. 2025;14:e240348.
    >> Share

  42. CHAUDHURY N, Crasto W, Saravanan P, Patel V, et al
    Intramuscular and subcutaneous levothyroxine: success in treating refractory hypothyroidism.
    Eur Thyroid J. 2025;14:e250012.
    >> Share

  43. NOWAK A, Podlewski J, Hubalewska-Dydejczyk A, Trofimiuk-Muldner M, et al
    The impact of insulin resistance on thyroid function and the prevalence of thyroid follicular nodular disease in pregnant women.
    Eur Thyroid J. 2025;14:e240317.
    >> Share

  44. ELOMAA K, Spick M, Gan EH, Pearce SH, et al
    Variable hyperthyroidism outcomes related to different treatment regimens: an analysis of UK Biobank data.
    Eur Thyroid J. 2025;14:e240393.
    >> Share

  45. SMOLDERS A, Kyrilli A, Constantinescu SM, Corvilain B, et al
    High-dose versus low-dose block-and-replace treatment for a first episode of Graves' disease.
    Eur Thyroid J. 2025;14:e250039.
    >> Share

  46. LUGARESI M, Moneta C, Saruggia G, Dionigi G, et al
    Changing the paradigm: lobectomy for sporadic medullary thyroid cancer.
    Eur Thyroid J. 2025;14:e250040.
    >> Share

  47. KIYOTA N, Koyama T, Sugitani I
    Anticancer drug therapy for anaplastic thyroid cancer.
    Eur Thyroid J. 2025;14:e240287.
    >> Share

  48. TAN J, Ge J, Wei Z, Sun B, et al
    Nomogram to predict the prognostic value of tumor deposits for patients with papillary thyroid carcinoma.
    Eur Thyroid J. 2025;14:e240343.
    >> Share

  49. MA Z, Mu R, Zhou Z, Hu Z, et al
    The mammalian acid chitinase promotes oncogenic properties of thyroid cancer cells through the JAK2/STAT3 pathway.
    Eur Thyroid J. 2025;14:e240311.
    >> Share

  50. PULIANI G, Bianchini M, Giani C, Valerio L, et al
    Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).
    Eur Thyroid J. 2025;14:e240386.
    >> Share

    February 2025
  51. ZHANG H, Wu S, Yang L, Fan C, et al
    Investigating factors influencing quality of life in thyroid eye disease: insight from machine learning approaches.
    Eur Thyroid J. 2025;14:e240292.
    >> Share

  52. KIM MJ, Moon JH, Lee EK, Song YS, et al
    A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea.
    Eur Thyroid J. 2025;14:e240281.
    >> Share

  53. DEMETRIOU E, Economides A, Fokou M, Lamnisos D, et al
    Adiposity is associated with a higher number of thyroid nodules and worse fine-needle aspiration outcomes.
    Eur Thyroid J. 2025;14:e240176.
    >> Share

  54. GRACA GM, Aguiar LR, De Lacerda L
    New diagnostic approach to central hypothyroidism after traumatic brain injury in children and adolescents.
    Eur Thyroid J. 2025;14:e240184.
    >> Share

  55. POTONNIER W, Guillerm E, Bigorgne C, Ghander C, et al
    Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytology.
    Eur Thyroid J. 2025;14:e240160.
    >> Share

  56. YAMAUCHI I, Yabe D
    Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors.
    Eur Thyroid J. 2025;14:e240328.
    >> Share

  57. LEE OW, Karyadi DM, Hartley SW, Zhou W, et al
    Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma.
    Eur Thyroid J. 2025;14:e240235.
    >> Share

  58. PORCELLI T, Luongo C, Cerbone A, Di Luccio C, et al
    Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?
    Eur Thyroid J. 2025;14:e240332.
    >> Share

  59. CARDO C, Bernardo Santos R, Pinotti Pedro Miklos AB, Barbosa Jaconis S, et al
    The relationship between cholesterol levels and thyroid eye disease.
    Eur Thyroid J. 2025;14:e240133.
    >> Share

  60. ARRIGONI M, Zwaveling-Soonawala N, LaFranchi SH, van Trotsenburg ASP, et al
    Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start.
    Eur Thyroid J. 2025;14:e240327.
    >> Share

  61. PICCARDO A, Fiz F, Righi S, Raffa S, et al
    [18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer.
    Eur Thyroid J. 2025;14:e240320.
    >> Share

  62. LIU M, Tang J, Sun N, Xi C, et al
    Pleural metastases from differentiated thyroid cancer: clinical features and long-term outcomes.
    Eur Thyroid J. 2025;14:e240147.
    >> Share

  63. DUTTA S, Knauf JA
    Development of animal models to study aggressive thyroid cancers.
    Eur Thyroid J. 2025;14:e240361.
    >> Share

  64. BOELEN A, Heijboer AC
    Newborn screening and the screening laboratory: past, present and future.
    Eur Thyroid J. 2025;14:e240325.
    >> Share

  65. VALDERRABANO P, Quinones Silva JB, Campos Mena S, Familiar Casado C, et al
    Evaluation of thyroid ultrasound reports' quality in the Community of Madrid, Spain.
    Eur Thyroid J. 2025;14:e240390.
    >> Share

  66. GARRELFS MR, Mooij CF, Boelen A, van Trotsenburg ASP, et al
    Newborn screening for central congenital hypothyroidism: past, present and future.
    Eur Thyroid J. 2025;14:e240329.
    >> Share

  67. PRASAI M, Lomre M, Jelloul E, Kleynen P, et al
    Higher prevalence of gestational diabetes in euthyroid women with thyroid autoimmunity who were expecting a female fetus.
    Eur Thyroid J. 2025;14:e240339.
    >> Share

  68. KUHLEN M, Kunstreich M, Eilsberger F, Luster M, et al
    Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis.
    Eur Thyroid J. 2025;14:e240341.
    >> Share

    December 2024
  69. RUCZ K, Hegedus L, Bonnema SJ, Frasoldati A, et al
    Echogenicity as a standalone nodule characteristic is not inferior to the TIRADS systems in the 10-20 mm nodule diameter range in patient selection for fine needle aspiration: a pilot study.
    Eur Thyroid J. 2024;13:e240149.
    >> Share

  70. MARINO M, Rotondo Dottore G, Menconi F, Comi S, et al
    Role of genetics and epigenetics in Graves' orbitopathy.
    Eur Thyroid J. 2024;13:e240179.
    >> Share

  71. PAUL J, Joseph A, Jebasingh F, More AR, et al
    Thyrotoxic periodic paralysis - a retrospective study from Southern India.
    Eur Thyroid J. 2024;13:e240164.
    >> Share

  72. CARLQVIST J, Nyman U, Brandberg J, Nystrom HF, et al
    Effects of iodine contrast media on thyroid function - a prospective study.
    Eur Thyroid J. 2024;13:e240244.
    >> Share

  73. FUJIKAWA M, Okamura K
    Graves' hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-up.
    Eur Thyroid J. 2024;13:e240085.
    >> Share

  74. ELGHAWY O, Barsouk A, Xu J, Chen S, et al
    Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240225.
    >> Share

  75. CONDELLO V, Juhlin CC
    MicroRNA regulator gene mutations in thyroid follicular nodular disease and thyroid cancer: does it all come down to timing?
    Eur Thyroid J. 2024;13:e240298.
    >> Share

    October 2024
  76. LEE HJ, Hah YS, Cheon SY, Won SJ, et al
    Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240079.
    >> Share

  77. LEE HJ, Hah YS, Cheon SY, Won SJ, et al
    Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240079.
    >> Share

  78. GAMBALE C, Prete A, Romei C, Celi A, et al
    Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib.
    Eur Thyroid J. 2024;13:e240189.
    >> Share

  79. ITO Y, Miyauchi A
    Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.
    Eur Thyroid J. 2024;13:e240196.
    >> Share

  80. PARK H, Heo J, Ryu HJ, Kim MJ, et al
    The association between BMI and BRAFV600E mutation may differ by primary tumor size.
    Eur Thyroid J. 2024;13:e230255.
    >> Share

  81. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Management of follicular thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240146.
    >> Share

  82. DAVID K, Van Crombrugge P, Van der Biest AM, D'Hondt F, et al
    Apalutamide-induced severe hypothyroidism: case series and practice recommendations for thyroid management.
    Eur Thyroid J. 2024;13:e240158.
    >> Share

  83. TSYBROVSKYY O, Sobrinho-Simoes M, Tallini G
    'Incidental thyroid cancer' is not synonymous with 'overdiagnosis'.
    Eur Thyroid J. 2024;13:e240283.
    >> Share

  84. COSME I, Figueiredo A, Pinheiro S, Leite V, et al
    Incidental thyroid cancer and overdiagnosis: response to Drs Tsybrovskyy, Sobrinho-Simoes, and Tallini.
    Eur Thyroid J. 2024;13:e240296.
    >> Share

  85. IMAI H, Watanabe N, Hirose R, Koshibu M, et al
    Subacute thyroiditis during pregnancy: clinical characteristics of seven cases.
    Eur Thyroid J. 2024;13:e240128.
    >> Share

  86. ZHAO C, Sun Z, Wang S, Zhang J, et al
    IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto's thyroiditis via the complement pathway.
    Eur Thyroid J. 2024;13:e240156.
    >> Share

    August 2024
  87. LAI KKH, Aljufairi FMAA, Sebastian JU, Wei Y, et al
    Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease.
    Eur Thyroid J. 2024;13:e230129.
    >> Share

  88. CHUNG CW, Kim K, Park SK, Ju DL, et al
    Selenium levels and their association with thyroid autoimmunity and severe preeclampsia in pregnancy: Insights from a prospective ideal breast milk cohort study.
    Eur Thyroid J. 2024;13:e240007.
    >> Share

  89. ZHANG Z, Yu J, Rainer E, Hargitai L, et al
    The role of [18F]F-DOPA PET/CT in diagnostic and prognostic assessment of medullary thyroid cancer: a 15-year experience with 109 patients.
    Eur Thyroid J. 2024;13:e240089.
    >> Share

  90. BARAN JA, Bojarsky M, Halada S, Ricarte-Filho JC, et al
    Low-invasive somatic oncogenes and lymph node metastasis in pediatric papillary thyroid cancer: implications for prophylactic central neck dissection.
    Eur Thyroid J. 2024;13:e230265.
    >> Share

  91. LEONCINI A, Camponovo C, Paone G, Gamarra E, et al
    Risk of TIRADS-based inappropriate FNAC in autonomous thyroid nodules is clinically negligible.
    Eur Thyroid J. 2024;13:e240123.
    >> Share

  92. MINALDI E, Cappagli V, Lorusso L, Valerio L, et al
    Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.
    Eur Thyroid J. 2024;13:e240009.
    >> Share

  93. PERSANI L, Rodien P, Moran C, Edward Visser W, et al
    2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action.
    Eur Thyroid J. 2024;13:e240125.
    >> Share

  94. HECHT F, Valerio L, Goncalves CFL, Harinquet M, et al
    A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.
    Eur Thyroid J. 2024;13:e240028.
    >> Share

  95. VAN HOUTEN P, Nagarajah J, Walraven JEW, Jaeger M, et al
    Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240153.
    >> Share

  96. ZHANG H, Wu S, Hu S, Fan X, et al
    Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease.
    Eur Thyroid J. 2024;13:e240122.
    >> Share

    June 2024
  97. COLOMBO C, Ceruti D, Succi M, De Leo S, et al
    Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex.
    Eur Thyroid J. 2024;13:e230246.
    >> Share

  98. SYED AR, Gorana A, Nohr E, Yuan XK, et al
    Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
    Eur Thyroid J. 2024;13:e230227.
    >> Share

  99. FUGAZZOLA L, Deandrea M, Borgato S, Dell'Acqua M, et al
    Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
    Eur Thyroid J. 2024;13:e240020.
    >> Share

  100. CIRELLO V, Lugaresi M, Moneta C, Dufour P, et al
    Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances and other persistent organic pollutants.
    Eur Thyroid J. 2024;13:e230192.
    >> Share

  101. TANG MOLLEHAVE L, Knudsen N, Linneberg A, Bulow Pedersen I, et al
    The Danish investigation on iodine intake and thyroid disease (DanThyr): history and implications.
    Eur Thyroid J. 2024;13:e230230.
    >> Share

  102. CHEN J, Li C, Teng W, Shan Z, et al
    A Chinese survey of clinical practice on the management of thyroid eye disease.
    Eur Thyroid J. 2024;13:e230269.
    >> Share

  103. MAVROMATI M, Caironi V, Saiji E, Vargas MI, et al
    Langerhans cell histiocytosis of the suprasellar region: diagnosis based on thyroid cytology.
    Eur Thyroid J. 2024;13:e240011.
    >> Share

  104. URSEM SR, Boelen A, Bruinstroop E, Elders PJM, et al
    A systematic review of subclinical hyperthyroidism guidelines: a remarkable range of recommendations.
    Eur Thyroid J. 2024;13:e240036.
    >> Share

  105. DEMARTIN S, Constantinescu SM, Poppe KG, Maiter D, et al
    Long-term hypothyroidism in patients started on levothyroxine during pregnancy.
    Eur Thyroid J. 2024;13:e240051.
    >> Share

  106. DE VINCENTIS S, Loiacono S, Zanni E, Sueri R, et al
    Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study.
    Eur Thyroid J. 2024;13:e240083.
    >> Share

    April 2024
  107. BARRETO MCA, Treistman N, Cavalcante LBCP, Bulzico D, et al
    Serum anti-Mullerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
    Eur Thyroid J. 2024;13:e230252.
    >> Share

  108. PITICCHIO T, Russ G, Radzina M, Frasca F, et al
    Head-to-head comparison of American, European, and Asian TIRADSs in thyroid nodule assessment: systematic review and meta-analysis.
    Eur Thyroid J. 2024;13:e230242.
    >> Share

  109. KOSTOPOULOS G, Effraimidis G
    Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.
    Eur Thyroid J. 2024;13:e230254.
    >> Share

  110. RIIS T, Bonnema SJ, Brix TH, Folkestad L, et al
    Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
    Eur Thyroid J. 2024;13:e230181.
    >> Share

  111. MULLER I, Maioli S, Armenti M, Porcaro L, et al
    Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.
    Eur Thyroid J. 2024;13:e230236.
    >> Share

  112. JU SH, Ji YB, Song M, Lim JY, et al
    Feasibility of active surveillance in patients with clinically T1b papillary thyroid carcinoma
    Eur Thyroid J. 2024;13:e230258.
    >> Share

  113. CROCE L, Beneventi F, Ripepi F, De Maggio I, et al
    Relationship between maternal obesity and first-trimester TSH in women with negative anti-TPO antibodies.
    Eur Thyroid J. 2024;13:e230213.
    >> Share

    February 2024
  114. HOU S, Sun Y, Yang Z, Tang M, et al
    The diagnostic value of GICA used for intraoperative lymph node FNA-Tg measurement to evaluate thyroid cancer metastases.
    Eur Thyroid J. 2024;13:e230182.
    >> Share

  115. HOLMBERG M, Malmgren H, Berglund PF, Johansson B, et al
    Psychiatric complications in Graves' disease.
    Eur Thyroid J. 2024;13:e230247.
    >> Share

  116. GIANOUKAKIS AG, Choe JH, Bowles DW, Brose MS, et al
    Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
    Eur Thyroid J. 2024;13:e230039.
    >> Share

  117. ZHANG H, Hu H, Wang Y, Duan X, et al
    Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter.
    Eur Thyroid J. 2024;13:e230109.
    >> Share

    December 2023
  118. MAVROMATI M, Saiji E, Demarchi MS, Lenoir V, et al
    Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.
    Eur Thyroid J. 2023;12:e230114.
    >> Share

  119. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
    Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
    Eur Thyroid J. 2023;12:e230105.
    >> Share

  120. GAMBALE C, Prete A, Contartese L, Torregrossa L, et al
    Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients.
    Eur Thyroid J. 2023;12:e230052.
    >> Share

  121. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
    Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
    Eur Thyroid J. 2023;12:e230049.
    >> Share

  122. JANSEN HI, van Haeringen M, Bouva MJ, den Elzen WPJ, et al
    Optimizing the Dutch newborn screening for congenital hypothyroidism by incorporating amino acids and acylcarnitines in a machine learning-based model.
    Eur Thyroid J. 2023;12:e230141.
    >> Share

  123. WU L, Vaccarella S, Feng CY, Dal Maso L, et al
    Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study.
    Eur Thyroid J. 2023;12:e230127.
    >> Share

  124. RIIS KR, Larsen CB, Medici BR, Jensen CZ, et al
    Hypothyroid women have persistently higher oxidative stress compared to healthy controls.
    Eur Thyroid J. 2023;12:e230167.
    >> Share

  125. WAN Z, Li Y, Dong X, Kang Y, et al
    Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men: a cross-sectional study.
    Eur Thyroid J. 2023;12:e230168.
    >> Share

  126. CONSTANTINESCU SM, Hospel J, Daumerie C, Alexopoulou O, et al
    Significance of thyroperoxidase and thyroglobulin antibodies in medically treated Graves' disease.
    Eur Thyroid J. 2023;12:e230193.
    >> Share

  127. TSENG HH, Lin YB, Lin KY, Lin CH, et al
    A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan.
    Eur Thyroid J. 2023;12:e230162.
    >> Share

  128. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
    Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
    Eur Thyroid J. 2023;12:e230049.
    >> Share

  129. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
    Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
    Eur Thyroid J. 2023;12:e230105.
    >> Share

  130. KYRILLI A, Tacelli N, Russo L, Lebrun L, et al
    Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.
    Eur Thyroid J. 2023;12:e230135.
    >> Share

  131. LEE YJ, Choi YH, Lim YH, Kim BN, et al
    Effects of iodine status on thyroid volume and goiter in children living in an iodine-replete area.
    Eur Thyroid J. 2023;12:e230219.
    >> Share

  132. HUSTED L, Rodgaard-Hansen S, Lundgaard MH, Uldall Torp NM, et al
    Biochemical markers of renal function and maternal hypothyroidism in early pregnancy.
    Eur Thyroid J. 2023;12:e230157.
    >> Share

  133. WON HR, Kim MG, Kim MS, Chang JW, et al
    Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence.
    Eur Thyroid J. 2023;12:e230195.
    >> Share

  134. BAHCECIOGLU AB, Gursoy A, Dizbay Sak S, Ilgan S, et al
    The sonographer's and pathologist's perspective of echogenic microfoci in papillary thyroid carcinoma.
    Eur Thyroid J. 2023;12:e230108.
    >> Share

  135. JIA HY, Chen J, Zhai ZX, Fan WW, et al
    Characterization of thyroid metastasis from clear cell renal cell carcinoma on ultrasonography: a report of three cases and literature review.
    Eur Thyroid J. 2023;12:e230121.
    >> Share

    October 2023
  136. DURANTE C, Hegedus L, Czarniecka A, Paschke R, et al
    2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.
    Eur Thyroid J. 2023;12:e230067.
    >> Share

  137. PINAR-GUTIERREZ A, Romero-Lluch AR, Duenas-Disotuar S, de Lara-Rodriguez I, et al
    Bone metastases from differentiated thyroid cancer: characteristics and prognostic factors in a multicenter series.
    Eur Thyroid J. 2023;12:e230086.
    >> Share

  138. FU J, Fan Z, He L, Liu Q, et al
    Circadian clock disruption in autoimmune thyroiditis.
    Eur Thyroid J. 2023;12:e230035.
    >> Share

  139. URSEM SR, Boelen A, Hillebrand JJ, den Elzen WPJ, et al
    How low can we (reliably) go? A method comparison of thyroid-stimulating hormone assays with a focus on low concentrations.
    Eur Thyroid J. 2023;12:e230123.
    >> Share

  140. MANSO J, Censi S, Clausi C, Piva I, et al
    Circulating miR-146a predicts glucocorticoid response in thyroid eye disease.
    Eur Thyroid J. 2023;12:e230083.
    >> Share

    August 2023
  141. WU J, Hu X, Seal P, Amin P, et al
    Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
    Eur Thyroid J. 2023;12:e230110.
    >> Share

  142. HALENKA M, Munteanu H, Obereigneru R, Dohnal R, et al
    Ethanol ablation of thyroid cysts in the young with a focus on efficacy and quality of life.
    Eur Thyroid J. 2023;12:e230085.
    >> Share

  143. SOLDEVILA B, Velasco I, Munoz C, Diaz Y, et al
    Longitudinal trajectories of maternal TSH in healthy pregnant women in Catalonia.
    Eur Thyroid J. 2023;12:e230016.
    >> Share

  144. CAPDEVILA J, Deandreis D, Durante C, Leboulleux S, et al
    Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.
    Eur Thyroid J. 2023;12:e230068.
    >> Share

  145. CAMPI I, Dell'Acqua M, Stellaria Grassi E, Cristina Vigone M, et al
    Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart.
    Eur Thyroid J. 2023;12:e230012.
    >> Share

  146. PERROS P, Hegedus L
    Teprotumumab in thyroid eye disease: wonder drug or great divider?
    Eur Thyroid J. 2023;12:e230043.
    >> Share

  147. JU N, Hou L, Song H, Qiu Z, et al
    TSH >/=30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
    Eur Thyroid J. 2023;12:e220219.
    >> Share

    July 2023
  148. NILSSON JN, Siikanen J, Condello V, Jatta K, et al
    Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.
    Eur Thyroid J. 2023;12:e230099.
    >> Share

  149. MO C, Chen H, Zhang Q, Guo Y, et al
    Central hyperthyroidism combined with Graves' disease: case series and review of the literature.
    Eur Thyroid J. 2023;12:e220223.
    >> Share

  150. BENABDELKAMEL H, Jaber MA, Dahabiyeh LA, Masood A, et al
    Metabolomic profile of patients on levothyroxine treatment for hypothyroidism.
    Eur Thyroid J. 2023;12:e230062.
    >> Share

  151. BOELEN A, Zwaveling-Soonawala N, Heijboer AC, van Trotsenburg ASP, et al
    Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?
    Eur Thyroid J. 2023;12:e230041.
    >> Share

  152. DAL MASO L, Pierannunzio D, Francisci S, De Paoli A, et al
    Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001-2018.
    Eur Thyroid J. 2023;12:e230051.
    >> Share

  153. SOARES MN, Borges-Canha M, Neves C, Neves JS, et al
    The role of Graves' disease in the development of thyroid nodules and thyroid cancer.
    Eur Thyroid J. 2023;12:e230055.
    >> Share

  154. JOHANSSON B, Holmberg M, Skau S, Malmgren H, et al
    The relationship between mental fatigue, depression, and cognition in Graves' disease.
    Eur Thyroid J. 2023;12:e230040.
    >> Share

  155. COLOMBO C, Ceruti D, De Leo S, Bilo G, et al
    Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.
    Eur Thyroid J. 2023;12:e230047.
    >> Share

    June 2023
  156. DIAS D, Damasio I, Marques P, Simoes H, et al
    Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin.
    Eur Thyroid J. 2023;12:e220227.
    >> Share

  157. KARA C, Mammadova J, Abur U, Gumuskaptan C, et al
    Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism.
    Eur Thyroid J. 2023;12:e220212.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016